Fortrea to Present at Upcoming J.P. Morgan Healthcare Conference
Fortrea (Nasdaq: FTRE) announced that CEO Anshul Thakral, CFO Jill McConnell, and SVP Investor Relations Tracy Krumme will present at the J.P.
Rhea-AI Summary
Fortrea (Nasdaq: FTRE) announced that CEO Anshul Thakral, CFO Jill McConnell, and SVP Investor Relations Tracy Krumme will present at the J.P. Morgan Annual Healthcare Conference in San Francisco.
The presentation and Q&A are scheduled for Tuesday, January 13, 2025 at 5:15 pm PST. A live webcast and replay will be available in the company’s Events section on Fortrea’s Investor Relations website. Investors seeking one-on-one meetings are asked to contact their banking representatives.
Details
News Market Reaction – FTRE
On Jan 6, the day this news came out, FTRE closed 5.54% above the previous close.
Data tracked by StockTitan Argus for the Jan 6 session.
Key Figures
- Conference date
- January 13, 2025
- J.P. Morgan Annual Healthcare Conference presentation
- Conference time
- 5:15 pm PST
- Scheduled J.P. Morgan presentation and Q&A
- Q3 2025 revenue
- $701.3 million
- Q3 2025 10‑Q revenue, up from $674.9 million year ago
- 9M 2025 revenue
- $2,062.9 million
- First nine months of 2025 total revenue
- 9M 2025 net loss
- $953.7 million
- Nine‑month net loss largely driven by goodwill impairments
- Goodwill impairments
- $797.9 million
- Impairments recorded in first half of 2025
- Long‑term debt
- $1,052.1 million
- Long‑term debt balance in Q3 2025 10‑Q
- Notes repurchased
- $75,743,000
- Senior secured notes repurchased in November 2025 tender offer
Historical Context
-
RSU grants to new hires under inducement plan, modest governance update.
-
Cell and gene therapy collaboration aligning CDMO manufacturing and CRO services.
-
Announcement of CEO/CFO participation in Citi and Evercore healthcare conferences.
-
Completion of $75.743M senior notes repurchase funded with cash on hand.
-
Appointment of new general counsel and chief compliance officer to leadership team.
24h Move is the share-price change in the day after each event; other market factors may also have contributed.
AI-generated analysis. How Rhea-AI works. Not financial advice.
DURHAM, N.C., Jan. 06, 2026 (GLOBE NEWSWIRE) -- Fortrea (Nasdaq: FTRE), a leading global contract research organization (CRO), today announced that CEO Anshul Thakral, CFO Jill McConnell, and SVP of Investor Relations, Tracy Krumme will participate in the following conference in January:
| J.P. Morgan Annual Healthcare Conference (San Francisco) | |
| Date: | Tuesday, January 13, 2025 |
| Time: | 5:15 pm PST |
| Format: | Presentation and Q&A |
The live webcast and replay can be accessed through the “Events” section of Fortrea’s Investor Relations website. Investors interested in one-on-one meetings should contact their banking representatives.
About Fortrea
Fortrea (Nasdaq: FTRE) is a leading global provider of clinical development solutions to the life sciences industry. We partner with emerging and large biopharmaceutical, biotechnology, medical device and diagnostic companies to drive healthcare innovation that accelerates life changing therapies to patients. Fortrea provides phase I-IV clinical trial management, clinical pharmacology and consulting services. Fortrea’s solutions leverage three decades of experience spanning more than 20 therapeutic areas, a passion for scientific rigor, exceptional insights and a strong investigator site network. Our talented and diverse team working in about 100 countries is scaled to deliver focused and agile solutions to customers globally. Learn more about how Fortrea is becoming a transformative force from pipeline to patient at Fortrea.com and follow us on LinkedIn and X (formerly Twitter).
Fortrea Contacts:
Tracy Krumme (Investors) – 984-385-6707, Tracy.Krumme@fortrea.com
Sue Zaranek (Media) – 919-943-5422, media@fortrea.com
Kate Dillon (Media) – 646-818-9115, kdillon@prosek.com
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.